Hyperlipemia therapeutic agent
US7022713B2 · kind B2 · utility
113Cited by
2References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 19, 2004 |
| Grant date | Apr 4, 2006 |
| Priority date | — |
| Expiry date | Feb 19, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a hyperlipemia therapeutic agent comprising pitavastatins and eicosapentaenoic acid or an ester derivative thereof as effective ingredients.According to the present invention, a type IIb and type IV hyperlipemia therapeutic agent having an excellent effect of lowering the cholesterol and triglyceride in blood is provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.